397 related articles for article (PubMed ID: 20739008)
1. Gestational trophoblastic disease II: classification and management of gestational trophoblastic neoplasia.
Lurain JR
Am J Obstet Gynecol; 2011 Jan; 204(1):11-8. PubMed ID: 20739008
[TBL] [Abstract][Full Text] [Related]
2. Development of single-agent chemotherapy regimens for gestational trophoblastic disease.
Homesley HD
J Reprod Med; 1994 Mar; 39(3):185-92. PubMed ID: 7518517
[TBL] [Abstract][Full Text] [Related]
3. 30 years' experience in the treatment of low-risk gestational trophoblastic neoplasia in Hungary.
Fülöp V; Szigetvári I; Szepesi J; Végh G; Bátorfi J; Nagymányoki Z; Török M; Berkowitz RS
J Reprod Med; 2010; 55(5-6):253-7. PubMed ID: 20626182
[TBL] [Abstract][Full Text] [Related]
4. Treatment of nonmetastatic and metastatic low-risk gestational trophoblastic neoplasia: factors associated with resistance to single-agent methotrexate chemotherapy.
Chapman-Davis E; Hoekstra AV; Rademaker AW; Schink JC; Lurain JR
Gynecol Oncol; 2012 Jun; 125(3):572-5. PubMed ID: 22449733
[TBL] [Abstract][Full Text] [Related]
5. Management of metastatic high-risk gestational trophoblastic neoplasia: FIGO stages II-IV: risk factor score > or = 7.
Lurain JR; Singh DK; Schink JC
J Reprod Med; 2010; 55(5-6):199-207. PubMed ID: 20626175
[TBL] [Abstract][Full Text] [Related]
6. Gestational trophoblastic neoplasia: an update.
Morgan JM; Lurain JR
Curr Oncol Rep; 2008 Nov; 10(6):497-504. PubMed ID: 18928664
[TBL] [Abstract][Full Text] [Related]
7. Low-risk gestational trophoblastic neoplasia and methotrexate resistance: predictors of response to treatment with actinomycin D and need for combination chemotherapy.
Growdon WB; Wolfberg AJ; Goldstein DP; Feltmate CM; Chinchilla ME; Lieberman ES; Berkowitz RS
J Reprod Med; 2010; 55(7-8):279-84. PubMed ID: 20795339
[TBL] [Abstract][Full Text] [Related]
8. High-risk gestational trophoblastic neoplasia with brain metastases: individualized multidisciplinary therapy in the management of four patients.
Soper JT; Spillman M; Sampson JH; Kirkpatrick JP; Wolf JK; Clarke-Pearson DL
Gynecol Oncol; 2007 Mar; 104(3):691-4. PubMed ID: 17137617
[TBL] [Abstract][Full Text] [Related]
9. Advances in management of high-risk gestational trophoblastic tumors.
Lurain JR
J Reprod Med; 2002 Jun; 47(6):451-9. PubMed ID: 12092013
[TBL] [Abstract][Full Text] [Related]
10. Treatment of metastatic gestational choriocarcinoma with oral methotrexate in a combat environment.
Farley JH; Heathcock RB; Branch W; Larsen W; Homas D
Obstet Gynecol; 2005 May; 105(5 Pt 2):1250-4. PubMed ID: 15863599
[TBL] [Abstract][Full Text] [Related]
11. Gestational trophoblastic disease I: epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole.
Lurain JR
Am J Obstet Gynecol; 2010 Dec; 203(6):531-9. PubMed ID: 20728069
[TBL] [Abstract][Full Text] [Related]
12. High-dose methotrexate for gestational trophoblastic disease.
Elit L; Covens A; Osborne R; Gerulath A; Murphy J; Rosen B; Sturgeon J
Gynecol Oncol; 1994 Sep; 54(3):282-7. PubMed ID: 7522198
[TBL] [Abstract][Full Text] [Related]
13. Actinomycin D for methotrexate-failed low-risk gestational trophoblastic neoplasia.
Lurain JR; Chapman-Davis E; Hoekstra AV; Schink JC
J Reprod Med; 2012; 57(7-8):283-7. PubMed ID: 22838241
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis and treatment of high-risk metastatic gestational trophoblastic neoplasia in Hungary.
Fülöp V; Szigetvŕi I; Szepesi J; Török M; Berkowitz RS
J Reprod Med; 2008 Jul; 53(7):541-6. PubMed ID: 18720931
[TBL] [Abstract][Full Text] [Related]
15. [Management of gestational trophoblastic disease].
Noal S; Joly F; Leblanc E
Gynecol Obstet Fertil; 2010 Mar; 38(3):193-8. PubMed ID: 20189434
[TBL] [Abstract][Full Text] [Related]
16. Treatment for low-risk gestational trophoblastic disease: comparison of single-agent methotrexate, dactinomycin and combination regimens.
Abrão RA; de Andrade JM; Tiezzi DG; Marana HR; Candido dos Reis FJ; Clagnan WS
Gynecol Oncol; 2008 Jan; 108(1):149-53. PubMed ID: 17931696
[TBL] [Abstract][Full Text] [Related]
17. Gestational trophoblastic diseases: 4. Presentation with persistent low positive human chorionic gonadotropin test results.
Cole LA; Khanlian SA; Giddings A; Butler SA; Muller CY; Hammond C; Kohorn E
Gynecol Oncol; 2006 Aug; 102(2):165-72. PubMed ID: 16631243
[TBL] [Abstract][Full Text] [Related]
18. Single-agent pulse dactinomycin has only modest activity for methotrexate-resistant gestational trophoblastic neoplasia.
Chen LM; Lengyel ER; Bethan Powell C
Gynecol Oncol; 2004 Jul; 94(1):204-7. PubMed ID: 15262143
[TBL] [Abstract][Full Text] [Related]
19. 25 years' experience in the treatment of gestational trophoblastic neoplasia in Hungary.
Szigetvári I; Szepesi J; Végh G; Bátorfi J; Arató G; Gáti I; Berkowitz RS; Fülöp V
J Reprod Med; 2006 Oct; 51(10):841-8. PubMed ID: 17086814
[TBL] [Abstract][Full Text] [Related]
20. Phase II trial of pulse dactinomycin as salvage therapy for failed low-risk gestational trophoblastic neoplasia: a Gynecologic Oncology Group study.
Covens A; Filiaci VL; Burger RA; Osborne R; Chen MD;
Cancer; 2006 Sep; 107(6):1280-6. PubMed ID: 16900525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]